𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and Efficacy of Simvastatin for the Treatment of Dyslipidemia in Human Immunodeficiency Virus-Infected Patients Receiving Efavirenz-Based Highly Active Antiretroviral Therapy

✍ Scribed by Dr. Anita P. Rahman; Dr. Susan A. Eaton; Dr. Sean T. Nguyen; Dr. Amy M. Bain; Dr. Kenna D. Payne; Dr. Roger Bedimo; Dr. Anthony J. Busti

Book ID
115049760
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
68 KB
Volume
28
Category
Article
ISSN
0277-0008

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Malignancy-related causes of death in hu
Malignancy-related causes of death in human immunodeficiency virus–infected patients in the era of highly active antiretroviral therapy
✍ Fabrice Bonnet; Charlotte Lewden; Thierry May; Laurence Heripret; Eric Jougla; S πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Before the introduction of highly active antiretroviral therapy (HAART), malignancies accounted for less than 10% of all deaths among human immunodeficiency virus (HIV)‐infected patients. This figure may have increased, and the observed types of malignant disease may have